News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,623 Results
Type
Article (39546)
Company Profile (327)
Press Release (655750)
Section
Business (206281)
Career Advice (2009)
Deals (35693)
Drug Delivery (89)
Drug Development (81923)
Employer Resources (170)
FDA (16143)
Job Trends (14944)
News (348499)
Policy (32655)
Tag
Academia (2538)
Alliances (49836)
Alzheimer's disease (1266)
Approvals (16105)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11683)
Biotechnology (232)
Breast cancer (189)
Cancer (1380)
Cardiovascular disease (112)
Career advice (1674)
Cell therapy (283)
Clinical research (65574)
Collaboration (493)
Compensation (266)
COVID-19 (2551)
C-suite (111)
Data (1398)
Diabetes (175)
Diagnostics (6181)
Earnings (85812)
Employer resources (148)
Events (112107)
Executive appointments (399)
FDA (16830)
Funding (430)
Gene therapy (195)
GLP-1 (608)
Government (4349)
Healthcare (18741)
Infectious disease (2644)
Inflammatory bowel disease (111)
Interviews (313)
IPO (16526)
Job creations (3672)
Job search strategy (1427)
Layoffs (422)
Legal (7887)
Lung cancer (198)
Manufacturing (208)
Medical device (13222)
Medtech (13227)
Mergers & acquisitions (19333)
Metabolic disorders (461)
Neuroscience (1591)
NextGen Class of 2024 (6526)
Non-profit (4481)
Northern California (1702)
Obesity (263)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (57138)
Phase I (20426)
Phase II (28927)
Phase III (21444)
Pipeline (514)
Postmarket research (2566)
Preclinical (8677)
Radiopharmaceuticals (244)
Rare diseases (265)
Real estate (5979)
Regulatory (21847)
Research institute (2323)
Resumes & cover letters (349)
Southern California (1472)
Startups (3608)
United States (15379)
Vaccines (567)
Weight loss (183)
Date
Today (106)
Last 7 days (574)
Last 30 days (2371)
Last 365 days (35616)
2024 (35455)
2023 (40473)
2022 (51633)
2021 (56245)
2020 (54474)
2019 (46901)
2018 (35315)
2017 (32507)
2016 (31947)
2015 (38018)
2014 (31843)
2013 (26766)
2012 (28940)
2011 (29608)
2010 (27666)
Location
Africa (723)
Arizona (197)
Asia (38206)
Australia (6201)
California (3844)
Canada (1458)
China (311)
Colorado (174)
Connecticut (179)
Europe (82578)
Florida (542)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (638)
Massachusetts (3010)
Michigan (175)
Minnesota (293)
New Jersey (1120)
New York (1095)
North Carolina (787)
Northern California (1702)
Ohio (146)
Pennsylvania (929)
South America (1105)
Southern California (1472)
Texas (560)
Utah (108)
Washington State (405)
695,623 Results for "provectus biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
·
5 min read
BioMidwest
Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders
Provectus Biopharmaceuticals, Inc. announced that its 2024 annual stockholder meeting, including meeting activities and a company update, will be accessible by Zoom Webinar.
June 13, 2024
·
5 min read
Business
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Provectus Biopharmaceuticals, Inc. today announced that data from preclinical research by the University of Calgary on oral administration of Provectus’s pharmaceutical-grade rose bengal for the treatments of solid tumor cancers were published in the open access journal of oncology Cancers.
April 18, 2024
·
4 min read
Business
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
Provectus Biopharmaceuticals, Inc. today announced additions to its executive leadership team, reflecting Provectus’s dedication to enhancing shareholder value.
April 16, 2024
·
6 min read
Press Releases
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024
·
3 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
October 25, 2024
·
3 min read
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting
Provectus Biopharmaceuticals, Inc. were presented at the annual meeting of the Association for Research in Vision and Ophthalmology (“ARVO”), held May 5-9, 2024 in Seattle, Washington.
May 14, 2024
·
6 min read
BioMidwest
Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
Provectus Biopharmaceuticals, Inc. announced that it has engaged IR Labs, Inc. to develop a comprehensive investor relations and corporate communications program for the Company.
February 14, 2024
·
3 min read
Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting
Provectus Biopharmaceuticals, Inc. announced posters were presented at the annual meeting of the Society for Investigative Dermatology (“SID”), held May 15-18, 2024 in Dallas, Texas.
May 21, 2024
·
5 min read
Business
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
Provectus Biopharmaceuticals, Inc. announced that it will host a conference call starting at 3 p.m. EST on Thursday, February 22, 2024, to provide Company updates.
February 15, 2024
·
3 min read
1 of 69,563
Next
